Urology Partners of North Texas Research Institute

Arlington, Texas 76017

1 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Overactive Bladder, Urologic Cancer, Urothelial Carcinoma

Studies at this site

• An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG — Available (expanded access)
• Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2) — Completed